ADH-503
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


ADH-503
Description :
ADH-503 ((Z) -Leukadherin-1 choline) is an orally active and allosteric CD11b agonist. ADH-503 leads to the repolarization of tumor-associated macrophages, reduction in the number of tumor-infiltrating immunosuppressive myeloid cells, and enhances dendritic cell responses[1].CAS Number :
[2055362-74-6]Product Name Alternative :
(Z) -Leukadherin-1 (choline)UNSPSC :
12352005Hazard Statement :
H302, H315, H319, H335Target :
Complement SystemType :
Reference compoundRelated Pathways :
Immunology/InflammationApplications :
Cancer-programmed cell deathField of Research :
CancerAssay Protocol :
https://www.medchemexpress.com/adh-503.htmlPurity :
98.04Solubility :
DMSO : 21.43 mg/mL (ultrasonic) |Ethanol : 3.33 mg/mL (ultrasonic; warming; heat to 60°C) |Methanol : 100 mg/mL (ultrasonic)Smiles :
O=C([O-])C1=CC=C(C2=CC=C(/C=C(SC(N3CC4=CC=CC=C4)=S)/C3=O)O2)C=C1.OCC[N+](C)(C)CMolecular Formula :
C27H28N2O5S2Molecular Weight :
524.65Precautions :
H302, H315, H319, H335References & Citations :
[1]Panni RZ, et al. Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies. Sci Transl Med. 2019 Jul 3;11 (499) .Shipping Conditions :
Room TemperatureStorage Conditions :
4°C (Powder, sealed storage, away from moisture)Scientific Category :
Reference compound1Clinical Information :
No Development Reported

